Catalent’s Partner, Amicus, Announces It Has Entered Into A Strategic Partnership With Catalent For Gene Therapy Development And Manufacturing




The agreement supports clinical and commercial supply needs for Pompe and other lysosomal disease gene therapy programs

Learn More